Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease

被引:5
作者
Sweeney, Jacob R. [1 ]
Crawford, Carl, V [2 ]
Yantiss, Rhonda K. [3 ]
机构
[1] Cleveland Clin, Dept Pathol & Lab Med, Cleveland, OH 44106 USA
[2] Weill Cornell Med, Div Gastroenterol & Hepatol, New York, NY USA
[3] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA
关键词
infection; Crohn disease; ulcerative colitis; pseudomembranous colitis; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; INFECTION; SOCIETY; UPDATE; COLECTOMY; DIARRHEA; ADULTS; RISK;
D O I
10.1111/his.14702
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims Patients with inflammatory bowel disease (IBD) are at increased risk for Clostridioides difficile infection, although clinically important infections can be difficult to recognise. C. difficile infection does not produce pseudomembranes when it occurs in IBD patients. These individuals may also be colonised by the organism, in which case diarrhoeal symptoms are not necessarily attributed to C. difficile. We performed this study to determine whether any features distinguished C. difficile-associated colitis from an IBD flare. Methods and results We reviewed the clinical, endoscopic and biopsy findings from 50 patients with established IBD and worsening diarrhoea, including 22 with concurrent positive C. difficile stool toxin polymerase chain reaction (PCR) assays and 28 with negative C. difficile assay results. We found that C. difficile-infected patients had symptoms and endoscopic findings that were indistinguishable from active IBD. Although most biopsy samples from patients with C. difficile infection showed chronic active colitis indistinguishable from IBD, some displayed neutrophilic infiltrates unaccompanied by plasma cell-rich inflammation involving superficial (41%) and crypt (18%) epithelium as well as neutrophilic infiltrates within lamina propria distant from foci of cryptitis (32%). All three of these features were significantly more common among infected than uninfected patients (4, 0 and 4%; P = 0.002, P = 0.03 and P = 0.02, respectively). Conclusions Although colonic biopsies from IBD patients with C. difficile infection usually lack features that aid distinction from colitic flares, some cases show an acute colitis pattern not seen in IBD alone. When identified in biopsies from symptomatic IBD patients, these changes should alert pathologists to the possibility of this clinically important infection.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
  • [31] Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficile
    Bolukcu, Sibel
    Hakyemez, Ismail Necati
    Gultepe, Bilge Sumbul
    Okay, Gulay
    Durdu, Bulent
    Koc, Meliha Meric
    Aslan, Turan
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2019, 25 (06) : 384 - 389
  • [32] Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience
    Jacob, Rachael
    Chu, Virginia
    Ng, Watson
    Williams, Astrid-Jane
    Connor, Susan
    INTERNAL MEDICINE JOURNAL, 2024, 54 (12) : 2009 - 2014
  • [33] Impact of Clostridium difficile on inflammatory bowel disease
    Ananthakrishnan, Ashwin N.
    Binion, David G.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) : 589 - 600
  • [34] Prevalence and sequelae of asymptomatic Clostridioides difficile colonization in children with inflammatory bowel disease
    Reasoner, Seth A.
    Zhang, Lisa S.
    Bernard, Rachel
    Edwards, Kathryn M.
    Nicholson, Maribeth R.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025, 80 (03) : 446 - 449
  • [35] Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease
    Azimirad, Masoumeh
    Krutova, Marcela
    Balaii, Hedieh
    Kodori, Mansoor
    Shahrokh, Shabnam
    Azizi, Omid
    Yadegar, Abbas
    Aghdaei, Hamid Asadzadeh
    Zali, Mohammad Reza
    ANAEROBE, 2020, 61
  • [36] Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for Clostridioides difficile
    Johnson, Lauren K.
    Munoz-Price, Silvia
    Patel, Poonam Beniwal
    Patel, Amir
    Stein, Daniel J.
    Yarur, Andres J.
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (02): : 135 - 139
  • [37] Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
    Abdehagh, Mohammad
    Azimirad, Masoumeh
    Houri, Hamidreza
    Nadalian, Banafsheh
    Azimirad, Fahimeh
    Olfatifar, Meysam
    Shoeibi, Ome Kolsoum Nasir
    Yadegar, Abbas
    Shahrokh, Shabnam
    Roshan, Mehran Mahdavi
    Aghdaei, Hamid Asadzadeh
    Zali, Mohammad Reza
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [38] Impact of Clostridioides difficile infection in patients admitted with ulcerative colitis
    Gros, Beatriz
    Soto, Pilar
    Causse, Manuel
    Marin, Sandra
    Iglesias, Eva
    Manuel Benitez, Jose
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (03) : 232 - 239
  • [39] Systematic review: Clostridium difficile and inflammatory bowel disease
    Goodhand, J. R.
    Alazawi, W.
    Rampton, D. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) : 428 - 441
  • [40] Clostridium difficile and Inflammatory Bowel Disease
    Issa, Mazen
    Ananthakrishnan, Ashwin N.
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (10) : 1432 - 1442